INVESTOR INTERVIEW WITH PATIENT HOME MONITORING CEO ED BERENBLUM POSTED ON PHM WEB SITE

SAN FRANCISCO, Jan. 19 /CNW/ - In connection with meetings during the J.P. Morgan Healthcare Conference in San Francisco, Patient Home Monitoring (PHM) (TSXV:PHM), a company focused on in-home cardiology healthcare services, today announced the release of an interview with the Company's CEO Ed Berenblum. The interview covers a brief history on PHM, the company's unique business model and Ed's move from Genpact (NYSE: G) to take on the position of Chief Executive Officer.

Investors can find the 40-minute in-depth interview on the PHM investor relations website: www.phmhometesting.com.

For additional information please refer to the Company's website and complete filings at www.sedar.com.

About PHM
PHM is a healthcare services company focused on providing in-home testing for patients on blood thinner medications such as Coumadin or warfarin. Medicare recently expanded reimbursement for in-home patient self testing (PST) of blood coagulation levels. PHM has a unique value proposition for cardiology groups that manage patients on blood thinners, focusing on systemization to enroll patients in PST. This unique, systemized approach creates an opportunity for physician groups to operate more efficiently, increasing revenue to their clinic while providing a higher standard of care for patients.

Information in this news release that is not current or historical factual information may constitute forward-looking information within the meaning of securities laws. Implicit in this information, particularly in respect of the future outlook of PHM and anticipated events or results, are assumptions based on beliefs of PHM's senior management as well as information currently available to it. While these assumptions were considered reasonable by PHM at the time of preparation, they may prove to be incorrect. Readers are cautioned that actual results are subject to a number of risks and uncertainties, including the availability of funds and resources to pursue operations, decline of reimbursement rates, dependence on few payors, possible new drug discoveries, a novel business model, dependence on key suppliers, granting of permits and licenses in a highly regulated business, competition, low profit market segments as well as general economic, market and business conditions, and could differ materially from what is currently expected.

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

SOURCE PHM Patient Home Monitoring

For further information:

Michael Dalsin
Chairman, Patient Home Monitoring
Managing Director, Stanmore Capital Partners, Inc.  
(323) 253-3055
mpd@stanmorecap.com
Michael Moore
Investor Relations
Equicom Group
619-467-7067
mmoore@equicomgroup.com

Organization Profile

PHM Patient Home Monitoring

More on this organization


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890